Advertisement
Former pharma executives sue over firings

Former pharma executives sue over firings

By Jay Greene  |  June 18, 2018

Two former executives of a biopharmaceutical company have filed a lawsuit against board members of their former employer, alleging violations of SEC rules and Michigan whistleblower laws that they contend led to their firings late last month.

Generic competition not a cure-all for high drug prices

Generic competition not a cure-all for high drug prices

By Alex Kacik  |  June 12, 2018

Although more generic drugs are coming through the pipeline, generic competition won't affect 46% of the estimated sales revenue of the top 100 drugs through 2023, according to a new report.

Insurer denials for hepatitis C treatment remain high

Insurer denials for hepatitis C treatment remain high

By Shelby Livingston  |  June 07, 2018

Despite the availability of hepatitis C drugs capable of curing most patients, public and private health insurers denied treatment for more than a third of patients whose doctors prescribed the drugs between 2016 and April 2017, according to a study.

Oncologists sue HHS over Medicare Part B sequester cuts

Oncologists sue HHS over Medicare Part B sequester cuts

By Susannah Luthi  |  May 31, 2018

The trade group for independent oncologists sued the federal government over the Medicare sequester cut to Part B drugs, arguing that Congress never gave HHS authority to change the reimbursement formula.

Data Points: Providers scramble as drug shortages persist

Data Points: Providers scramble as drug shortages persist

By Modern Healthcare  |  May 26, 2018

Drug shortages continue to keep providers across the nation scrambling to find options for patient care. A new survey from the American College of Emergency Physicians found that 9 in 10 doctors are taking time away from patients as they search for alternative therapies.

Worsening drug shortages leave providers scrambling for alternatives

Worsening drug shortages leave providers scrambling for alternatives

By Alex Kacik  |  May 21, 2018

Ninety-one percent of nearly 250 emergency physicians surveyed in a new ACEP poll said they had experienced a shortage or absence of critical medicine in their emergency department in the past month. That increases costs and compromises care.

Shorter breast cancer treatment could hurt providers' bottom line

Shorter breast cancer treatment could hurt providers' bottom line

By Alex Kacik  |  May 17, 2018

Women who use the breast cancer drug Herceptin for six months did just as well as those who took it for a year, according to a new study that could ultimately benefit value-based providers and harm those still based on fee-for-service models.

Advertisement
X

Subscribe and SAVE 50%

View our best offer
Subscribe to Print